PHEX and cervical cancer: Moreover, the antiproliferative effect of HYP has not been studied in cell lines originating from squamous cervical cancer cells (SiHa, CasKi, and C33A), which represent the predominant type of cervical cancer globally (accounting for 75%-85% of all cases) (119, 120).